Table 4 Self-reported symptoms the 640 ’past SARS-CoV-2 infection’ participants experienced from March 1st to August 31st 2020 during their COVID-19 episode. Chi-squared statistics (χ2) was used to compare the residents with the staff members
Symptom | Resident (n=188) | Staff (n=452) | Total (n=640) | χ2p-value |
|---|---|---|---|---|
No symptoms | 111 (59%) | 127 (28.1%) | 238 (37.2%) | <0.0001 |
Fatigue | 40 (21.3%) | 256 (56.6%) | 296 (46.2%) | <0.0001 |
Ageusia and/or anosmia | 12 (6.4%) | 202 (44.7%) | 214 (33.4%) | <0.0001 |
Headache | 7 (3.7%) | 195 (43.1%) | 202 (31.6%) | <0.0001 |
Cough | 34 (18.1%) | 149 (33.0%) | 183 (28.6%) | <0.0001 |
Dyspnea | 30 (16.0%) | 148 (32.7%) | 178 (27.8%) | <0.0001 |
Fever | 39 (20.7%) | 141 (31.2%) | 180 (28.1%) | 0.0098 |
Pain (any) | 11 (5.9%) | 120 (26.5%) | 131 (20.5%) | <0.0001 |
Muscle pain | 5 (2.7%) | 99 (21.9%) | 104 (16.2%) | <0.0001 |
Joint pain | 2 (1.1%) | 76 (16.8%) | 78 (12.2%) | <0.0001 |
Chest pain | 2 (1.1%) | 53 (11.7%) | 55 (8.6%) | <0.0001 |
Abdominal pain | 1 (0.5%) | 16 (3.5%) | 17 (2.7%) | 0.06 |
Shivering | 4 (2.1%) | 118 (26.1%) | 122 (19.1%) | <0.0001 |
Sore throat | 5 (2.7%) | 116 (25.7%) | 121 (18.9%) | <0.0001 |
Rhinitis | 7 (3.7%) | 87 (19.2%) | 94 (14.7%) | <0.0001 |
Diarrhoea | 13 (6.9%) | 70 (15.5%) | 83 (13.0%) | 0.0049 |
Nausea | 7 (3.7%) | 46 (10.2%) | 53 (8.3%) | 0.0111 |
Confused | 7 (3.7%) | 23 (5.1%) | 30 (4.7%) | 0.59 |
Anorexia | 6 (3.2%) | 22 (4.9%) | 28 (4.4%) | 0.46 |
Worsening prior respiratory problems | 4 (2.1%) | 11 (2.4%) | 15 (2.3%) | 1.00 |
Rash | 0 (0.0%) | 10 (2.2%) | 10 (1.6%) | 0.09 |